Akira Kato, Shionogi CEO
Shionogi to provide global access to its antibiotics, with focus on poor countries, as resistance fears grow
As the world faces a growing challenge of pathogens resistant to antibiotics, Shionogi and the GARDP have committed to an execution of a license and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
